Picture of Australian Clinical Labs logo

ACL — Australian Clinical Labs News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Australia's competition regulator opposes Australian Clinical Labs' offer to buy Healius

Dec 15 (Reuters) - Australia's competition regulator
said on Friday it had decided to oppose the proposed acquisition
of Healius Limited  HLS.AX  by Australian Clinical Labs.
 ACL.AX  

 (Reporting by Archishma Iyer in Bengaluru; Editing by Shinjini
Ganguli)
 ((Archishma.Iyer@thomsonreuters.com;))

Recent news on Australian Clinical Labs

See all news